Back to BlackRock, Inc. BlackRock, Inc.

KYTXKYTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KYVERNA THERAPEUTICS INC

BlackRock, Inc. holds 3.1M shares of KYTX (KYVERNA THERAPEUTICS INC), worth $27.9M as of 2026-Q2. The position was increased (+257.4% shares). KYTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$27.9M

Current Shares

3.1M

Total Value Change

+$21.7M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+257.4%
$27.9M0.0%$8.91
46
2026-Q1
Increased
877,078
+61.1%
$7.6M0.0%$8.02
40
2025-Q4
Increased
544,539
+13.0%
$5.1M0.0%$9.35
30
2025-Q3
Decreased
482,054
-9.6%
$2.9M0.0%$5.94
0
2025-Q2
Decreased
533,467
-68.2%
$1.6M0.0%$3.28
0
2025-Q1
Increased
1.7M
+0.2%
$3.2M0.0%$2.00
26
2024-Q4
New
1.7M
-
$6.3M0.0%$3.64
38

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc., MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used